Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
NCT06932263
This study is recruiting at 22 US sites in 15 states, according to its ClinicalTrials.gov record last updated .
Summary
This is a dose-range finding, double-blind, placebo-controlled, phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolled asthma receiving medium-to-high dose inhaled corticosteroids.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Asthma
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- AstraZeneca
- Last updated on ClinicalTrials.gov
- September 25, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 3
- Research Site · Bakersfield, CA
- Research Site · Newport Beach, CA
- Research Site · San Jose, CA
Indiana · 1
- Research Site · Noblesville, IN
Kentucky · 1
- Research Site · Louisville, KY
Michigan · 1
- Research Site · Farmington Hills, MI
Nebraska · 2
- Research Site · Grand Island, NE
- Research Site · Omaha, NE
New Jersey · 1
- Research Site · Toms River, NJ
New York · 1
- Research Site · Maspeth, NY
North Carolina · 1
- Research Site · Kings Mountain, NC
Ohio · 1
- Research Site · Toledo, OH
Oregon · 2
- Research Site · Medford, OR
- Research Site · Portland, OR
Pennsylvania · 2
- Research Site · Philadelphia, PA
- Research Site · Smithfield, PA
South Carolina · 1
- Research Site · Rock Hill, SC
Texas · 3
- Research Site · Austin, TX
- Research Site · Kingwood, TX
- Research Site · Victoria, TX
West Virginia · 1
- Research Site · Kingwood, WV
Wisconsin · 1
- Research Site · Milwaukee, WI
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.